Treatment of stable chronic obstructive pulmonary disease

Lancet
S I Rennard

Abstract

Chronic obstructive pulmonary disease (COPD) is a readily diagnosable disorder that responds to treatment. Smoking cessation can reduce symptoms and prevent progression of disease. Bronchodilator therapy is key in improvement of lung function. Three classes of bronchodilators-beta agonists, anticholinergics, and theophylline-are available and can be used individually or in combination. Inhaled glucocorticoids can also improve airflow and can be combined with bronchodilators. Inhaled glucocorticoids, in addition, might reduce exacerbation frequency and severity as might some bronchodilators. Effective use of pharmacotherapy in COPD needs integration with a rehabilitation programme and successful treatment of co-morbidities, including depression and anxiety. Treatment for stable COPD can improve the function and quality of life of many patients, could reduce admissions to hospital, and has been suggested to improve survival.

References

Oct 1, 1992·The American Review of Respiratory Disease·T F Murphy, S Sethi
Sep 1, 1989·The American Review of Respiratory Disease·R M Davis, T E Novotny
Feb 1, 1987·Annals of Internal Medicine·N R AnthonisenN A Nelson
Mar 22, 1995·JAMA : the Journal of the American Medical Association·S SaintD Grady
Sep 22, 1994·The New England Journal of Medicine·K L NicholT Von Sternberg
Jan 1, 1993·Respiration; International Review of Thoracic Diseases·P ArgyropoulouD Georgopoulos
Feb 1, 1996·Proceedings of the Society for Experimental Biology and Medicine·A A Abdel-Latif
Aug 1, 1996·American Journal of Respiratory and Critical Care Medicine·W H ThompsonJ J Crowley
Jun 1, 1996·The Psychiatric Clinics of North America·K Franco-Bronson
Apr 1, 1997·American Journal of Respiratory and Critical Care Medicine·P W Jones, T K Bosh
Oct 23, 1997·The New England Journal of Medicine·R D HurtP M Sullivan
Dec 23, 1998·Psychopharmacology·M S MumenthalerJ A Yesavage
Mar 4, 1999·The New England Journal of Medicine·D E JorenbyT B Baker
Apr 20, 1999·Chest·D A MahlerW H Anderson
Aug 3, 1999·American Journal of Respiratory and Critical Care Medicine·D E O'DonnellK A Webb
Apr 14, 2000·American Journal of Respiratory and Critical Care Medicine·M R LittnerT J Witek
Nov 10, 2000·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·J R HughesS A Heatley
Dec 6, 2000·The European Respiratory Journal·P Tønnesen, K L Mikkelsen
Jan 3, 2001·The New England Journal of Medicine·UNKNOWN Lung Health Study Research GroupMelissa Skeans
Jan 6, 2001·Journal of Cardiopulmonary Rehabilitation·R GosselinkM Decramer
Mar 16, 2001·Expert Opinion on Pharmacotherapy·R Pineda, S I Rennard
May 24, 2001·American Journal of Respiratory and Critical Care Medicine·L S OnR W Costello
May 30, 2001·Lancet·C Silagy, N Formica
Jun 19, 2001·The European Respiratory Journal·A M ScholsE F Wouters
Aug 25, 2001·American Journal of Respiratory and Critical Care Medicine·D D Sin, J V Tu
Sep 11, 2001·American Journal of Respiratory and Critical Care Medicine·D E O'DonnellK A Webb
Sep 11, 2001·American Journal of Respiratory and Critical Care Medicine·R DahlUNKNOWN Formoterol in Chronic Obstructive Pulmonary Disease I Study Group
Oct 10, 2001·Chest·H K SingerJ T Barth

❮ Previous
Next ❯

Citations

Jan 19, 2005·Der Internist·H R Wirtz
Jul 14, 2007·International Journal of Clinical Practice·D Bellamy, J Smith
Jun 24, 2006·BMJ : British Medical Journal·Graeme P CurrieBrian J Lipworth
Jun 2, 2006·Thorax·R Rodríguez-Roisin
Aug 6, 2005·American Journal of Respiratory and Critical Care Medicine·Jonathan M Samet
Nov 30, 2007·International Journal of Chronic Obstructive Pulmonary Disease·Mario Cazzola, Nicola A Hanania
Nov 30, 2007·International Journal of Chronic Obstructive Pulmonary Disease·Paolo Montuschi
Nov 19, 2011·Respiration; International Review of Thoracic Diseases·Johan BuffelsMarc Decramer
Mar 1, 2005·Current Opinion in Infectious Diseases·Michael J Parnham
Aug 19, 2015·Pulmonary Pharmacology & Therapeutics·E D BatemanK F Rabe
Apr 11, 2012·Emergency Medicine Clinics of North America·Cory A Brulotte, Eddy S Lang
Apr 11, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Hussein A N Al-WadeiMohammed H Al-Wadei
Nov 19, 2005·Revue des maladies respiratoires·P Godard, B Housset
Apr 23, 2011·Journal of Psychosomatic Research·Karin F HothKristen E Holm
Jan 28, 2009·La Presse médicale·Yves-Marie AllainNicolas Roche
Nov 29, 2015·Emergency Medicine Clinics of North America·Salvador J Suau, Peter M C DeBlieux
Jul 29, 2008·British Journal of Pharmacology·D Spina
Sep 13, 2008·Journal of the American Academy of Nurse Practitioners·Kim K KueblerCynthia R Balkstra
Oct 5, 2010·The Clinical Respiratory Journal·Charlotte Suppli Ulrik, Peter Michael Anthony Calverley
May 4, 2006·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·George S AlexopoulosRichard S Novitch
May 4, 2005·Lancet·James F Donohue
Apr 14, 2012·Current Opinion in Pharmacology·Clive P Page, Domenico Spina
Jun 2, 2007·Respiratory Medicine·Renay TaylorMartyn R Partridge
Dec 28, 2011·Journal of Psychosomatic Research·Melissa R PlaufcanKristen E Holm
Nov 14, 2006·Chest·Kristina CrothersUNKNOWN Veterans Aging Cohort 5 Project Team
Mar 18, 2017·International Journal of Molecular Sciences·Joshua B LewisPaul R Reynolds
Feb 2, 2006·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·David G TinkelmanR J Halbert
Dec 8, 2004·Lancet·Edwin J Wagena
Dec 30, 2017·Molecular Genetics and Genomics : MGG·Yan WangWenju Lu
Jun 7, 2007·British Journal of Community Nursing·Gretl McHughKaren Luker
Feb 6, 2021·Journal of Complementary & Integrative Medicine·Ali Mohamed Ali IsmailAhmed Mohamed Abdelhalim Elfahl

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.